Dr. Reddy's Laboratories shares are trading higher after the company announced it signed a definitive agreement with Haleon for purchase of shares of Northstar Switzerland SARL to acquire its global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy category outside of the United States.
$RDY
Biotechnology: Pharmaceutical Preparations
Health Care
Dr. Reddy's Laboratories shares are trading higher after the company announced it signed a definitive agreement with Haleon for purchase of shares of Northstar Switzerland SARL to acquire its global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy category outside of the United States.